Navigation Links
Women Faces No Risk on Discontinuation of Osteoporosis Drug

tial study was named the Fracture Intervention Trial or FIT, and its results were reported in 1996 and 1998.

The follow-up study now being reported is known as FLEX, for FIT Long-Term Extension. It was designed to evaluate the effects on BMD for a total of 10 years, comparing those who continued to take the drug with those who stopped after five years. A total of 1,099 women who had previously received alendronate in FIT and afterwards, were re-randomized to receive placebo or alendronate at 5 mg or 10 mg daily.

According to Black, findings showed that "women randomized to continue taking alendronate did maintain a higher BMD at the hip and spine than those randomized to placebo. For those who stopped, there was a modest loss of BMD, but not a dramatic loss."

The study found differences in bone loss in those who continued versus those who stopped but the differences were surprisingly modest and there were no differences in rates of non-spine fractures or in spine fractures as assessed by comparison of spine x-rays. Severe spine fractures associated with painful symptoms were lower in those who continued but were relatively rare overall (5 percent in those who discontinued vs. 2.5 percent among those who continued drug treatment).

In the United States, osteoporosis affects about 44 million people age 50 and older, and of these, 80 percent are postmenopausal women.

According to Black, "Older people are often taking several different medications. But for many women, if they can discontinue one treatment after five years, it would also be a welcome lifestyle change and will decrease their overall costs for medical care."

A typical regimen requires the patient to drink a full glass of water with the drug on an empty stomach and sit upright for up to 30 minutes.

While the results suggest discontinuation of the treatment for some women, women at a very high risk of clinical spine fract
'"/>




Page: 1 2 3

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
(Date:12/1/2008)...ecent release of data from the National Oncologic ...the moment of critical mass by confirming the effe... the monitoring of tumor activity across a wide ra...study, we verified that PET finds more areas of ac... some cases, to earlier initiation of subsequent t...
(Date:12/1/2008)...rthopaedic surgeon is the driving force for a safe... Dec. 1 /PRNewswire-USNewswire/ - - While many pa...musculoskeletal injury may be anxious to get back ... get behind the wheel of a car can be a difficult ...concerns of orthopaedic surgeons and patients alik...
(Date:12/1/2008)...RNewswire/ -- Sciton introduces ProLipo,PLUS(TM),...wered laser system,for ablating and melting unwan...sue tightening. ProLipo PLUS combines 1064 nm and...y sculpting results. Frequently used as an adjunc...ized as a standalone procedure,for patients who a...
(Date:12/1/2008)... An independent study at the,Univ...ngsters want to play,video games at the same time...xercise. , Fifty children aged 11 and 12 we...video games provided by a company called Gamercize...y while they maintained movement on,the fitness m...
Breaking Medicine News(10 mins):Health News:Nationwide study confirms PET as the most powerful imaging tool in cancer management 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 3Health News:Sciton Introduces ProLipo PLUS(TM), the Most Robust Laser-Assisted Lipolysis System Available 2Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2
...unger and older Americans have been declining sinc...really knows why// . Those are the findings of a ...f South Carolina and released Thursday (Sept. 28) ... American Journal of Public Health. Dr. Robert Mc...
...ad Institute of MIT and Harvard announced today th...hat can connect human diseases// with potential dr...s work in human cells. Called the 'Connectivity Ma...e September 29 issue of Science and in separate pu...
...ming microsurgery in Tanzania from a computer term... experts// in Vietnam presenting an avian influenz...ins outpatient center. These are some of the possi...ation system that will be used for the first time ...
...coli infection from tainted spinach. E. coli exper...earch scholar at the University// of British Colum...a place a death grip on intestinal cells. Finlay's...i, information that could aid in development of a ...
Other Medicine News:Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3Health News:High-Speed Internet2 Link Revolutionizes Global Medical Education 2
(Date:11/24/2008)...TO, Nov. 24 /PRNewswire-FirstCall/ - Predictive me...ay announced that it has entered into a fully fund...rld,s largest cosmetic companies. PreMD,s PREVU* s...ith one of the cosmetic company,s skin care produc...arlier successful study completed by PreMD with th...
(Date:11/24/2008)...ASHINGTON, Nov. 24 , ...st four year Presidential term will start with bil.... As spokesman for the Repair Stem Cell,Institut...ll research and,treatment industry worldwide, I w...support for our industry and the medical and scien...
(Date:11/24/2008)...OPHIA ANTIPOLIS, France, November 24 /PRNewswire-F...) today announced that the third pivotal phase,3 ...ip showed a highly,statistically significant resu...endpoints of the trial. Naproxcinod 750 mg bid sho...rate and a similar blood pressure profile,to plac...
(Date:11/23/2008)...ILLE, Tenn., Nov. 24 A new cancer ...t pancreatic cancer. Following five weeks,of trea...d in size by 70%.,After seven more weeks of treat... on scans. Pancreatic cancer usually is fatal six ...n,s combination of FDA-approved drugs,appears to ...
Breaking Medicine Technology:PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate 2Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute 2Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 2Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 3Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 5New Cancer Treatment Shrinks Pancreatic Tumor 2 26quot 3BBrave New Reality 26quot 3B Provides a Wide Spectrum of High Tech News and Easy Science 6320 1 26quot 3BBrave New Reality 26quot 3B Provides a Wide Spectrum of High Tech News and Easy Science 6320 2 26quot 3BBrave New Reality 26quot 3B Provides a Wide Spectrum of High Tech News and Easy Science 6320 3Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch New Endurance Products SR L Arginine and Grape Seed Extrac 22994 1Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch New Endurance Products SR L Arginine and Grape Seed Extrac 22994 2Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch New Endurance Products SR L Arginine and Grape Seed Extrac 22994 3Flaws in the barcoded technology used to reduce medication administration errors identified 22991 1Flaws in the barcoded technology used to reduce medication administration errors identified 22991 2Flaws in the barcoded technology used to reduce medication administration errors identified 22991 3Flaws in the barcoded technology used to reduce medication administration errors identified 22991 4Violence declines with medication use in some with schizophrenia 22987 1Violence declines with medication use in some with schizophrenia 22987 2
...nd Other Human,Papillomavirus Related Diseases Aft...III Clinical Studies Which Included More Than,17,0...hes the most comprehensive,and robust clinical dat...nce, 10th May2007 – New clinical study resul...asil® in the,prevention of cervical cancer and...
...tisense,Pharma today announced, that the abstract ...I-Study in Pancreatic,Carcinoma, Malignant Melanom...ibitor AP 12009” has been selected for poste...merican Society of,Clinical Oncology (ASCO), which...ne 1st - 5th. , In the Phase I/II-trial the antise...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2
The KY is a low profile implantable bipolar fixed screw-in permanent pacing lead for stimulation of either the atrium or the ventricle. The KY lead is supplied with a screwdriver shape stylet which i
The Vitatron Pirouet S+ lead series are endocardial leads with extendable/retractable helical screw designed for reliable fixation and optimal pacing characteristics.
Implantable medical grade silicone sleeve for adapting a 5 mm (01) connector to a 6 mm (02) connector.
...e only ICD system in the world for biatrial stimul... of interatrial connection blockages. The patients...ynamics and long term protection against cardiac r...ffectively suppress the typical symptomatic and me...
Medicine Products: